Guido J. Neels's most recent trade in Axogen Inc. was a trade of 4,073 Common Stock done at an average price of $10.6 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc. | Guido J. Neels | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 09 Jun 2025 | 4,073 | 86,743 (0%) | 0% | 10.6 | 43,215 | Common Stock |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 32,282 | 32,282 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 85,241 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc. | Guido J. Neels | Director | 01 Sep 2024 | 11,904 | 90,816 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 58,748 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc. | Guido J. Neels | Director | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | ||
| Axogen Inc. | Guido J. Neels | Director | 06 Jun 2024 | 10,653 | 78,912 (0%) | 0% | - | Common Stock | ||
| Axogen Inc. | Guido J. Neels | Director | 16 Aug 2023 | 10,000 | 68,259 (0%) | 0% | 6.1 | 61,100 | Common Stock | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 28,348 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2023 | 6,459 | 58,259 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2023 | 6,459 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2022 | 11,811 | 11,811 | - | - | Stock Option (right to purchase) | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2022 | 6,459 | 6,459 | - | - | Restricted Stock Units | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2022 | 3,036 | 51,800 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2022 | 3,036 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 11,700 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 9,000 (0%) | 0% | - | Class A Common Stock | |
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2021 | 6,173 | 0 | - | - | Restricted Stock Units | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2021 | 6,173 | 48,764 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2021 | 6,030 | 6,030 | - | - | Stock Option (right to purchase) | ||
| Axogen Inc. | Guido J. Neels | Director | 01 Jun 2021 | 3,036 | 3,036 | - | - | Restricted Stock Units | ||
| Axogen Inc. | Guido J. Neels | Director | 19 May 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | ||
| Axogen Inc. | Guido J. Neels | Director | 19 May 2021 | 25,000 | 27,591 (0%) | 0% | 3.8 | 95,000 | Common Stock | |
| Axogen Inc. | Guido J. Neels | Director | 19 May 2021 | 15,000 | 0 | - | - | Stock Option (right to purchase) | ||
| Axogen Inc. | Guido J. Neels | Director | 19 May 2021 | 15,000 | 42,591 (0%) | 0% | 5.1 | 76,350 | Common Stock | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 2,700 | 2,700 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,000 | 9,000 | - | - | Restricted Stock Units | |
| Axogen Inc. | Guido J. Neels | Director | 03 Sep 2020 | 2,591 | 2,591 (0%) | 0% | 11.7 | 30,444 | Common Stock |